Surgery – Internal organ support or sling
Reexamination Certificate
2005-06-07
2005-06-07
Lucchesi, Nicholas D. (Department: 3763)
Surgery
Internal organ support or sling
C600S016000, C604S020000, C607S009000
Reexamination Certificate
active
06902522
ABSTRACT:
A device for treating cardiac disease of a heart having an upper portion and a lower portion divided by an A–V groove, the device including a jacket adapted to be secured to the heart, and a delivery source for the delivery of one or more therapeutic agents to the surface of the heart. The jacket is fabricated from a flexible material defining a volume between an upper and a lower end, the jacket being adapted to be adjusted on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain expansion of the heart beyond the maximum adjusted volume during diastole and permit substantially unimpeded contraction of the heart during systole. As a result of the flexible material, the jacket allows unimpeded diastolic filling of the heart. Also described is a method for treating cardiac disease including surgically accessing the heart, applying the treatment device of the invention, securing the treatment device to the heart, and surgically closing access to the heart while leaving the treatment device on the heart.
REFERENCES:
patent: 3983863 (1976-10-01), Janke et al.
patent: 4048990 (1977-09-01), Goetz
patent: 4428375 (1984-01-01), Ellman
patent: 4630597 (1986-12-01), Kantrowitz et al.
patent: 4690134 (1987-09-01), Snyders
patent: 4821723 (1989-04-01), Baker, Jr. et al.
patent: 4827932 (1989-05-01), Ideker et al.
patent: 4878890 (1989-11-01), Bilweis
patent: 4936857 (1990-06-01), Kulik
patent: 4957477 (1990-09-01), Lundback
patent: 4973300 (1990-11-01), Wright
patent: 4976730 (1990-12-01), Kwan-Gett
patent: 5057117 (1991-10-01), Atweh
patent: 5087243 (1992-02-01), Avitall
patent: 5131905 (1992-07-01), Grooters
patent: 5150706 (1992-09-01), Cox et al.
patent: 5186711 (1993-02-01), Epstein
patent: 5192314 (1993-03-01), Daskalakis
patent: 5256132 (1993-10-01), Snyders
patent: 5290217 (1994-03-01), Campos
patent: 5356432 (1994-10-01), Rutkow et al.
patent: 5383840 (1995-01-01), Heilman et al.
patent: 5385156 (1995-01-01), Oliva
patent: 5429584 (1995-07-01), Chiu
patent: 5507779 (1996-04-01), Altman
patent: 5524633 (1996-06-01), Heaven et al.
patent: 5603337 (1997-02-01), Jarvik
patent: 5647380 (1997-07-01), Campbell et al.
patent: 5702343 (1997-12-01), Alferness
patent: 5713954 (1998-02-01), Rosenberg et al.
patent: 5800528 (1998-09-01), Lederman et al.
patent: 5961440 (1999-10-01), Schweich, Jr. et al.
patent: 5990378 (1999-11-01), Ellis
patent: 6045497 (2000-04-01), Schweich, Jr. et al.
patent: 6050936 (2000-04-01), Schweich, Jr. et al.
patent: 6059715 (2000-05-01), Schweich, Jr. et al.
patent: 6077218 (2000-06-01), Alferness
patent: 6085754 (2000-07-01), Alferness et al.
patent: 6123662 (2000-09-01), Alferness et al.
patent: 6126590 (2000-10-01), Alferness
patent: 6165121 (2000-12-01), Alferness
patent: 6165122 (2000-12-01), Alferness
patent: 6174279 (2001-01-01), Girard
patent: 6241654 (2001-06-01), Alferness
patent: 6296630 (2001-10-01), Altman et al.
patent: 6375608 (2002-04-01), Alferness
patent: 6416459 (2002-07-01), Haindl
patent: 6425856 (2002-07-01), Shapland et al.
patent: 6432039 (2002-08-01), Wardle
patent: 6482146 (2002-11-01), Alferness et al.
patent: 6537203 (2003-03-01), Alferness et al.
patent: 6544168 (2003-04-01), Alferness
patent: 295 17 393 U 1 (1996-03-01), None
patent: 0 280 564 (1988-08-01), None
patent: 60-203250 (1985-10-01), None
patent: 01-145066 (1989-06-01), None
patent: 1009457 (1983-04-01), None
patent: WO 9829041 (1998-07-01), None
patent: WO 9858598 (1998-12-01), None
patent: WO 9916381 (1999-04-01), None
patent: WO 9944534 (1999-09-01), None
patent: WO 0002500 (2000-01-01), None
patent: WO 0006026 (2000-02-01), None
patent: WO 0006027 (2000-02-01), None
patent: WO 0006028 (2000-02-01), None
patent: WO 0016700 (2000-03-01), None
“Supplement to Circulation”,Abstracts from the 68th Scientific Sessions, vol. 92, No. 8, 2 pages (Oct. 15, 1995).
Capomolla, S. et al., “Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: Hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function”,American Heart Journal, pp. 1089-1098 (Dec. 1997).
Capoyua, E. et al., “Girdling Effect of Nanstimulated Cardiomyoplasty on Left Ventricular Function”,Ann Thorac. Surg., vol. 56, pp. 867-871 (1993).
Cohn, J., “The Management of Chronic Heart Failure”,The New England Journal of Medicine, vol. 335, No. 7, pp. 490-498 (Aug. 15, 1996).
Coletta, C. et al., Prognostic value of left ventricular volume response during dobutamine stress echocardiography:,European Heart Journal, vol. 18, pp. 1599-1605 (Oct. 1997).
Guasp, F., “Una prótesis contentiva para el tratamiento de la miocardiopatía dilatada”,Revista Española de Cardiología, vol. 51, No. 7, pp. 521-528 (Jul. 1998).
Kass, D. et al., “Reverse Remodeling From Cardiomyoplasty in Human Heart Failure External Constraint Versus Active Assist”,Circulation, vol. 91, No. 9, pp. 2314-2318 (May 1, 1995).
Levin, H. et al., “Reversal of Chronic Ventricular Dilation in Patient With End-Stage Cardiomyopathy of Prolong Mechanical Unloading”,Circulation, vol. 91, No. 11, pp. 2717-2720 (Jun. 1, 1995).
Oh, J. et al., “The Effects Of Prosthetic Cardiac Binding and Adynamic Cardiomyoplasty In A Model Of Dilated Cardiomyopathy”,The Journal of Thoracic and Cardiovascular Surgery, vol. 116, No. 1, pp. 148-153 (Jul. 1998).
Paling, D., “Warp Knitting Technology”,Columbine Press, p. 111 (1965).
Vaynblat, M. et al., “Cardiac Binding in Experimental Heart Failure”,Ann. Thorac. Surg., vol. 64, 11 pages, (1997).
Avitall, B. et al., “Iontophoretic Transmyocardial Drug Delivery A Novel Approach to Antiarrhythmic Drug Therapy”,Circulation, vol. 85, No. 4, pp. 1582-1593 (Apr. 1992).
Kessler, P.D. et al., “Myoblast Cell Grafting into Heart Muscle: Cellular Biology and Potential Applications”,Annu. Rev. Physiol.,vol. 61, pp. 219-242 (1999).
Labhasetwar, V. et al., “Sotalol Controlled-Release Systems for Arrhthmias: In Vitro Characterization, in Vivo Drug Disposition, and Electrophysiologic Effects”,Journal of Pharmaceutical Sciences.,vol. 83, No. 2, pp. 156-164 (Feb. 1994).
Labhasetwar, V. et al., “Epicardial Administration of Ibutilide from Polyurethane Matrices: Effects of Defibrillation Threshold and Electrophysiologic Parameters”,J. Cardiovasc. Pharmacol., vol. 24, No. 5, pp. 826-840 (1994).
Labhasetwar, V. et al., “Iontophoresis for Modulation of Cardiac Drug Delivery in Dogs”,Proc. Natl. Acad. Sci. USA, vol. 92, pp. 2612-2616 (Mar. 1995).
Labhasetwar, V. et al., “A DNA Controlled-Release Coating for Gene Transfer: Transfection in Skeletal and Cardiac Muscle”,Journal of Pharmaceutical Sciences, vol. 87, No. 11, pp. 1347-1350 (Nov. 1998).
Labhasetwar, V. et al., “Prevention of Acute Inducible Atrial Flutter in Dogs by Using an Ibutilide-Polymer-Coated Pacing Electrode”,J. Cardiovasc. Pharmacol.,vol. 31, No. 3, pp. 449-455 (1998).
Li, R. et al., “Cell Therapy to Repair Broken Hearts”,Can. J. Cardiol., vol. 14, No. 5, pp. 735-744 (May 1998).
Mond, H. et al., “The Steroid-Eluting Electrode: A 10-Year Experience”,PACE, vol. 19, pp. 1016-1020 (Jul. 1996).
Siden, R. et al., “Epicardial Controlled-Relase Verapamil Prevents Ventricular Tachycardia Episodes Induced by Acute Ischemia in a Canine Model”,J. Cardiovasc. Pharmacol.,vol. 19, No. 5, pp. 798-809 (1992).
Siden, R. et al., “Epicardial Propanolol Administration for Ventricular Arrhythmias in Dogs: Matrix Formulation and Characterization”,Biomaterials, vol. 13, No. 11, pp. 764-770 (1992).
Sintov, A. et al., “Efficacy of Epicardial Controlled-Release Lidocaine for Ventricular Tachycardia Induced by Rapid Ventricular Pacing in Dogs”,J. Cardiovasc. Pharmacol., vol. 16, No. 5, pp. 812-817 (1990).
Palme, II Donald F.
Rohrbaugh Donald G.
Shapland, II J. Edward
Walsh Robert G.
Acorn Cardiovascular Inc.
Lucchesi Nicholas D.
Maiorino Roz
LandOfFree
Cardiac disease treatment and device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac disease treatment and device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac disease treatment and device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480371